A prospective cohort study of intrauterine infusion of platelet-rich plasma in the treatment of intrauterine adhesions

Application of platelet-rich plasma intrauterine perfusion in the treatment of intrauterine adhesions

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100048317

Enrollment

Unknown

Registered

2021-07-05

Start date

2021-07-01

Completion date

Unknown

Last updated

2022-03-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intrauterine adhesion

Interventions

PRP perfusion group:Postoperative intrauterine infusion of PRP

No PRP perfusion group:None

Eligibility

Sex/Gender

Female

Age

20 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1.Intrauterine adhesion was diagnosed by hysteroscopy; 2.Aged 20 to 40 years; 3.BMI 18 to 25 kg/m^2; 4.Hysteroscopic separation of intrauterine adhesions was performed.

Exclusion criteria

Exclusion criteria: 1.Combined with single horn uterus, double horn uterus, remnant horn uterus, primary base uterus, juvenile uterus, uterine mediastinum, uterine submucosal fibroids; 2.Combined with polycystic ovary syndrome and severe endometritis.

Design outcomes

Primary

Measure	Time frame
Ongoing pregnancy rate;LIve birth rate;	—

Secondary

Measure	Time frame
The time after operation for the uterine cavity to return to normal;Endometrial thickness during ovulation;Menstrual pattern;Miscarriage rate;	—

Countries

China

Contacts

Public ContactZhang Wanlin

The Second Affiliated Hospital of PLA Air Force Military Medical University

fenglingwanwan@qq.com+86 18149363396

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026